{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:31:27Z","timestamp":1790987487602,"version":"4.1.0"},"reference-count":210,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG) 2015 Id.17758"],"award-info":[{"award-number":["IG) 2015 Id.17758"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.thromres.2020.12.002","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T17:18:56Z","timestamp":1607707136000},"page":"139-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"198","author":[{"given":"Alessandro","family":"Ciavarella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gnocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Custodero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro Mariano","family":"Lenato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Sabb\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mazzocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2020.12.002_bb0005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0010","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.3748\/wjg.v20.i26.8407","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease","volume":"20","author":"Liu","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0015","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/lt.24134","article-title":"Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis","volume":"21","author":"Stine","year":"2015","journal-title":"Liver Transpl."},{"key":"10.1016\/j.thromres.2020.12.002_bb0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41424-018-0002-y","article-title":"Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis","volume":"9","author":"Stine","year":"2018","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2020.12.002_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000341127","article-title":"Nonalcoholic fatty liver disease: what the pathologist can tell the clinician","volume":"30","author":"Brunt","year":"2012","journal-title":"Dig. Dis."},{"key":"10.1016\/j.thromres.2020.12.002_bb0030","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"White","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0035","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2020.12.002_bb0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jgh.12212","article-title":"Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches","volume":"28","author":"Schuppan","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0045","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2014a new world-wide definition. A consensus statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet. Med."},{"key":"10.1016\/j.thromres.2020.12.002_bb0050","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/0016-5085(90)91169-7","article-title":"Effect of weight reduction on hepatic abnormalities in overweight patients","volume":"99","author":"Palmer","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0168-8278(97)80287-5","article-title":"Therapeutic effects of restricted diet and exercise in obese patients with fatty liver","volume":"27","author":"Ueno","year":"1997","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0060","first-page":"221","article-title":"Molecular pathways in non-alcoholic fatty liver disease","volume":"7","author":"Berlanga","year":"2014","journal-title":"Clin. Exp. Gastroenterol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0065","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00109-009-0464-1","article-title":"Molecular mechanisms involved in NAFLD progression","volume":"87","author":"Malaguarnera","year":"2009","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.thromres.2020.12.002_bb0070","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0075","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3748\/wjg.v20.i7.1768","article-title":"Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"20","author":"Zhang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0080","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/10715762.2013.837577","article-title":"Involvement of free radicals and oxidative stress in NAFLD\/NASH","volume":"47","author":"Sumida","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.thromres.2020.12.002_bb0085","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.dld.2012.11.010","article-title":"Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies","volume":"45","author":"Frasinariu","year":"2013","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.thromres.2020.12.002_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1586\/egh.11.28","article-title":"Fibrogenesis in nonalcoholic steatohepatitis","volume":"5","author":"De Minicis","year":"2011","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/5584_2016_121","article-title":"Venous and arterial thrombosis: is there a link?","volume":"906","author":"Prandoni","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0105","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.thromres.2007.09.010","article-title":"The metabolic syndrome and the risk of arterial and venous thrombosis","volume":"122","author":"Franchini","year":"2008","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.12.002_bb0110","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-0029-1234140","article-title":"The metabolic syndrome as a risk factor for venous and arterial thrombosis","volume":"35","author":"Dentali","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2020.12.002_bb0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clinre.2016.07.005","article-title":"Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases","volume":"41","author":"Motamed","year":"2017","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0120","series-title":"Fact Sheet on Cardiovascular Diseases","author":"WHO","year":"2017"},{"key":"10.1016\/j.thromres.2020.12.002_bb0125","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0130","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0135","doi-asserted-by":"crossref","first-page":"33386","DOI":"10.1038\/srep33386","article-title":"Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2020.12.002_bb0140","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.18632\/oncotarget.22755","article-title":"Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis","volume":"9","author":"Hu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.thromres.2020.12.002_bb0145","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/hep.21103","article-title":"Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C","volume":"43","author":"Sanyal","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0150","first-page":"376","article-title":"The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome","volume":"36","author":"Alper","year":"2008","journal-title":"Turk. Kardiyol. Dern. Ars"},{"key":"10.1016\/j.thromres.2020.12.002_bb0155","first-page":"273","article-title":"Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography","volume":"9","author":"Acikel","year":"2009","journal-title":"Anadolu Kardiyol. Derg."},{"key":"10.1016\/j.thromres.2020.12.002_bb0160","first-page":"867","article-title":"Association between non-alcoholic fatty liver disease and coronary artery disease severity","volume":"124","author":"Sun","year":"2011","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.thromres.2020.12.002_bb0165","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jjcc.2012.05.003","article-title":"The association between impaired collateral circulation and non-alcoholic fatty liver in patients with severe coronary artery disease","volume":"60","author":"Arslan","year":"2012","journal-title":"J. Cardiol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0170","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/ene.13556","article-title":"Non-alcoholic fatty liver disease is associated with stroke severity and progression of brainstem infarctions","volume":"25","author":"Li","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0175","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1253\/circj.72.618","article-title":"Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT)","volume":"72","author":"Akabame","year":"2008","journal-title":"Circ. J."},{"key":"10.1016\/j.thromres.2020.12.002_bb0180","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1148\/radiol.09090769","article-title":"Presence of coronary plaques in patients with nonalcoholic fatty liver disease","volume":"254","author":"Assy","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0185","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1148\/radiol.14140933","article-title":"High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial","volume":"274","author":"Puchner","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0190","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00535-018-1516-5","article-title":"Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter","volume":"54","author":"Park","year":"2019","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11886-009-0004-1","article-title":"Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease","volume":"11","author":"Johnsen","year":"2009","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.thromres.2020.12.002_bb0200","first-page":"7673","article-title":"Association between nonalcoholic fatty liver disease and carotid atherosclerosis: a meta-analysis","volume":"8","author":"Cai","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.thromres.2020.12.002_bb0205","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.atherosclerosis.2012.06.005","article-title":"Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians","volume":"223","author":"Thakur","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2020.12.002_bb0210","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1161\/01.ATV.0000189299.61568.79","article-title":"Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease","volume":"25","author":"Targher","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0215","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0220","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/hep4.1199","article-title":"Association of hepatic steatosis with subclinical atherosclerosis: systematic review and meta-analysis","volume":"2","author":"Kapuria","year":"2018","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.thromres.2020.12.002_bb0225","doi-asserted-by":"crossref","first-page":"E165","DOI":"10.1111\/hepr.12554","article-title":"Association of non-alcoholic fatty liver disease with impaired endothelial function by flow-mediated dilation: a meta-analysis","volume":"46","author":"Fan","year":"2016","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.thromres.2020.12.002_bb0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12933-018-0670-7","article-title":"Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study","volume":"17","author":"Tuttolomondo","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0235","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1097\/MEG.0000000000000909","article-title":"Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"29","author":"Jaruvongvanich","year":"2017","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejim.2018.03.010","article-title":"Fatty liver index is associated to pulse wave velocity in healthy subjects: data from the Brisighella Heart Study","volume":"53","author":"Cicero","year":"2018","journal-title":"Eur. J. Int. Med."},{"key":"10.1016\/j.thromres.2020.12.002_bb0245","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.thromres.2020.12.002_bb0250","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3748\/wjg.v13.i10.1579","article-title":"Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease","volume":"13","author":"Hamaguchi","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0255","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2013.07.052","article-title":"A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?","volume":"230","author":"Oni","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2020.12.002_bb0260","doi-asserted-by":"crossref","first-page":"l5367","DOI":"10.1136\/bmj.l5367","article-title":"Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults","volume":"367","author":"Alexander","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2020.12.002_bb0265","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0270","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/MCG.0000000000000834","article-title":"Portal vein thrombosis in cirrhosis","volume":"51","author":"Loudin","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0275","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1160\/TH16-06-0450","article-title":"The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis","volume":"117","author":"Ambrosino","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.12.002_bb0280","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1572-0241.2006.00588.x","article-title":"Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism","volume":"101","author":"Northup","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0285","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.3748\/wjg.v16.i48.6119","article-title":"High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism","volume":"16","author":"Di Minno","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0290","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0032-1306425","article-title":"Hypercoagulation and thrombophilia in nonalcoholic fatty liver disease: mechanisms, human evidence, therapeutic implications, and preventive implications","volume":"32","author":"Northup","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.thromres.2020.12.002_bb0295","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.dld.2017.01.147","article-title":"AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions","volume":"49","author":"L. Italian Association for the Study of the","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.thromres.2020.12.002_bb0300","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.thromres.2020.12.002_bb0305","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/sleep\/33.9.1193","article-title":"Consequences of comorbid sleep apnea in the metabolic syndrome--implications for cardiovascular risk","volume":"33","author":"Trombetta","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.thromres.2020.12.002_bb0310","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/17512433.2018.1519391","article-title":"LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature","volume":"11","author":"Ravnskov","year":"2018","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0315","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.coph.2004.10.003","article-title":"Hypercoagulability in the metabolic syndrome","volume":"5","author":"Nieuwdorp","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0320","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1467-789X.2011.00930.x","article-title":"Platelet activation in obesity and metabolic syndrome","volume":"13","author":"Santilli","year":"2012","journal-title":"Obes. Rev."},{"key":"10.1016\/j.thromres.2020.12.002_bb0325","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1665-2681(19)31746-6","article-title":"Altered clot kinetics in patients with non-alcoholic fatty liver disease","volume":"8","author":"Hickman","year":"2009","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0330","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2020.12.002_bb0335","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.thromres.2020.12.002_bb0340","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3343\/alm.2015.35.1.15","article-title":"Influence of blood lipids on global coagulation test results","volume":"35","author":"Kim","year":"2015","journal-title":"Ann. Lab Med."},{"key":"10.1016\/j.thromres.2020.12.002_bb0345","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1161\/01.ATV.17.8.1539","article-title":"Coagulation factor VII and the risk of coronary heart disease in healthy men","volume":"17","author":"Junker","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0350","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0021-9150(92)90015-9","article-title":"Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein-lipase deficiency","volume":"95","author":"Mitropoulos","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2020.12.002_bb0355","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"Forstermann","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2020.12.002_bb0360","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12876-017-0592-y","article-title":"Non alcoholic fatty liver disease and eNOS dysfunction in humans","volume":"17","author":"Persico","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0365","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.freeradbiomed.2014.05.016","article-title":"Regulation of obesity and insulin resistance by nitric oxide","volume":"73","author":"Sansbury","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.thromres.2020.12.002_bb0370","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1128\/MCB.23.16.5726-5737.2003","article-title":"Activation of the phosphatidylinositol 3-kinase\/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis","volume":"23","author":"Kawasaki","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0375","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1074\/jbc.275.9.6123","article-title":"Enhanced electron flux and reduced calmodulin dissociation may explain \u201ccalcium-independent\u201d eNOS activation by phosphorylation","volume":"275","author":"McCabe","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2020.12.002_bb0380","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1172\/JCI3030","article-title":"Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action","volume":"102","author":"Shankar","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2020.12.002_bb0385","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10238-015-0347-4","article-title":"Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients","volume":"16","author":"Paredes-Turrubiarte","year":"2016","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.thromres.2020.12.002_bb0390","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1074\/jbc.M309552200","article-title":"Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells","volume":"279","author":"Anderson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2020.12.002_bb0395","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCRESAHA.108.173963","article-title":"Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1","volume":"103","author":"Yan","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.thromres.2020.12.002_bb0400","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/01.RES.73.1.205","article-title":"Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life","volume":"73","author":"Yoshizumi","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.thromres.2020.12.002_bb0405","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj3570593","article-title":"Nitric oxide synthases: structure, function and inhibition","volume":"357","author":"Alderton","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.thromres.2020.12.002_bb0410","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1160\/TH06-09-0498","article-title":"Coagulation and endothelial dysfunction during longterm hyperdynamic porcine bacteremia\u2014effects of selective inducible nitric oxide synthase inhibition","volume":"97","author":"Matejovic","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.12.002_bb0415","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.plipres.2005.11.002","article-title":"Ceramides in insulin resistance and lipotoxicity","volume":"45","author":"Summers","year":"2006","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.thromres.2020.12.002_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126910","article-title":"Ceramide as a mediator of non-alcoholic fatty liver disease and associated atherosclerosis","volume":"10","author":"Kasumov","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2020.12.002_bb0425","doi-asserted-by":"crossref","first-page":"41231","DOI":"10.1038\/srep41231","article-title":"Mechanistic interplay between ceramide and insulin resistance","volume":"7","author":"Reali","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2020.12.002_bb0430","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2012.04.005","article-title":"Role of ceramides in nonalcoholic fatty liver disease","volume":"23","author":"Pagadala","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.thromres.2020.12.002_bb0435","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/db11-1399","article-title":"Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.thromres.2020.12.002_bb0440","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1743-7075-8-25","article-title":"Impact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans","volume":"8","author":"Chen","year":"2011","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.thromres.2020.12.002_bb0445","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/ATVBAHA.109.199281","article-title":"Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: multi-ethnic study of atherosclerosis","volume":"30","author":"Yeboah","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0450","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1161\/ATVBAHA.110.213363","article-title":"Selective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis","volume":"30","author":"Fan","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0455","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1161\/01.CIR.0000148370.60535.22","article-title":"Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice","volume":"110","author":"Park","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2020.12.002_bb0460","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1478-3231.2008.01920.x","article-title":"Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease","volume":"29","author":"Yun","year":"2009","journal-title":"Liver Int."},{"key":"10.1016\/j.thromres.2020.12.002_bb0465","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ahj.2003.11.020","article-title":"Impaired glucose tolerance and cardiovascular disease: the possible role of post-prandial hyperglycemia","volume":"147","author":"Ceriello","year":"2004","journal-title":"Am. Heart J."},{"key":"10.1016\/j.thromres.2020.12.002_bb0470","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/ATVBAHA.109.189290","article-title":"Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study","volume":"29","author":"Heit","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0475","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1160\/TH14-10-0868","article-title":"Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism. A population-based cohort study","volume":"114","author":"Chung","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.12.002_bb0480","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2337\/dc08-0282","article-title":"Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome","volume":"31","author":"Undas","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.thromres.2020.12.002_bb0485","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.2337\/diacare.24.8.1476","article-title":"Platelet dysfunction in type 2 diabetes","volume":"24","author":"Vinik","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.thromres.2020.12.002_bb0490","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0735-1097(95)00518-8","article-title":"Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes","volume":"27","author":"Aoki","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0495","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/BF00401055","article-title":"Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects","volume":"36","author":"Ceriello","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.thromres.2020.12.002_bb0500","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.96.7.2262","article-title":"Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE","volume":"96","author":"Bierhaus","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2020.12.002_bb0505","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/db09-1008","article-title":"Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin","volume":"59","author":"Gerrits","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.thromres.2020.12.002_bb0510","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4093\/dmj.2017.0105","article-title":"The role of advanced glycation end products in diabetic vascular complications","volume":"42","author":"Rhee","year":"2018","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.thromres.2020.12.002_bb0515","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1172\/JCI115014","article-title":"Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes","volume":"87","author":"Bucala","year":"1991","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2020.12.002_bb0520","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.2119\/molmed.2015.00067","article-title":"Advanced glycation end products: a molecular target for vascular complications in diabetes","volume":"21","author":"Yamagishi","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.thromres.2020.12.002_bb0525","doi-asserted-by":"crossref","first-page":"43836","DOI":"10.1074\/jbc.M106534200","article-title":"Regulation of vascular endothelial growth factor expression by advanced glycation end products","volume":"276","author":"Treins","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2020.12.002_bb0530","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/156720206775541804","article-title":"Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes","volume":"3","author":"Takenaka","year":"2006","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.thromres.2020.12.002_bb0535","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/biom5010194","article-title":"Advanced glycation end products and oxidative stress in type 2 diabetes mellitus","volume":"5","author":"Nowotny","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.thromres.2020.12.002_bb0540","doi-asserted-by":"crossref","first-page":"7A","DOI":"10.1016\/S0002-9149(02)03144-2","article-title":"Role of oxidative stress in atherosclerosis","volume":"91","author":"Harrison","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0545","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1073\/pnas.0601056103","article-title":"Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice","volume":"103","author":"Dumas","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.thromres.2020.12.002_bb0550","doi-asserted-by":"crossref","first-page":"19076","DOI":"10.1038\/srep19076","article-title":"Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2020.12.002_bb0555","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.thromres.2020.12.002_bb0560","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004947","article-title":"Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies","volume":"6","author":"Heianza","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.thromres.2020.12.002_bb0565","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/jcmm.13307","article-title":"Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies","volume":"22","author":"Qi","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.thromres.2020.12.002_bb0570","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tmrv.2014.09.006","article-title":"The fibrinolytic system-more than fibrinolysis?","volume":"29","author":"Draxler","year":"2015","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/j.thromres.2020.12.002_bb0575","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(87)93050-9","article-title":"Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction","volume":"2","author":"Hamsten","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2020.12.002_bb0580","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/STROKEAHA.107.498600","article-title":"Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis","volume":"39","author":"Arenillas","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2020.12.002_bb0585","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12959-018-0166-4","article-title":"Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis","volume":"16","author":"Jung","year":"2018","journal-title":"Thromb. J."},{"key":"10.1016\/j.thromres.2020.12.002_bb0590","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000080884.27358.49","article-title":"Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease","volume":"108","author":"Anand","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2020.12.002_bb0595","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1073\/pnas.89.15.6998","article-title":"Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries","volume":"89","author":"Schneiderman","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.thromres.2020.12.002_bb0600","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.RES.80.4.490","article-title":"Plasminogen activator inhibitor type 1 and tissue inhibitor of metalloproteinases-2 increase after arterial injury in rats","volume":"80","author":"Hasenstab","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.thromres.2020.12.002_bb0605","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.CIR.103.4.576","article-title":"Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice","volume":"103","author":"Konstantinides","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2020.12.002_bb0610","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1182\/blood.V96.13.4212","article-title":"Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery","volume":"96","author":"Eitzman","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.12.002_bb0615","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.atherosclerosis.2009.10.011","article-title":"Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease","volume":"209","author":"Sookoian","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2020.12.002_bb0620","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MBC.0b013e328337b3f8","article-title":"Hemostatic alterations in fatty liver disease","volume":"21","author":"Kargili","year":"2010","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2020.12.002_bb0625","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.26510","article-title":"Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"59","author":"Verrijken","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0630","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.2337\/dc07-0109","article-title":"Plasma PAI-1 levels are increased in patients with nonalcoholic steatohepatitis","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.thromres.2020.12.002_bb0635","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MPG.0b013e3181c7bdf1","article-title":"Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children","volume":"50","author":"Alisi","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.thromres.2020.12.002_bb0640","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.2047-6310.2012.00082.x","article-title":"Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease","volume":"7","author":"Fitzpatrick","year":"2012","journal-title":"Pediatr. Obes."},{"key":"10.1016\/j.thromres.2020.12.002_bb0645","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/ijpo.12183","article-title":"Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease","volume":"13","author":"Jin","year":"2018","journal-title":"Pediatr. Obes."},{"key":"10.1016\/j.thromres.2020.12.002_bb0650","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jgh.12705","article-title":"Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders","volume":"30","author":"Chang","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0655","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.ATV.0000077401.36885.BB","article-title":"Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation","volume":"23","author":"Alessi","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0660","doi-asserted-by":"crossref","first-page":"89746","DOI":"10.18632\/oncotarget.21120","article-title":"TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.thromres.2020.12.002_bb0665","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/hep4.1259","article-title":"Inhibition of plasminogen activator inhibitor 1 attenuates hepatic steatosis but does not prevent progressive nonalcoholic steatohepatitis in mice","volume":"2","author":"Henkel","year":"2018","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.thromres.2020.12.002_bb0670","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","article-title":"The interactions between inflammation and coagulation","volume":"131","author":"Esmon","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0675","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1464-5491.2005.01646.x","article-title":"Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue","volume":"22","author":"Targher","year":"2005","journal-title":"Diabet. Med."},{"key":"10.1016\/j.thromres.2020.12.002_bb0680","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.ATV.21.5.731","article-title":"Elevated factor VIII levels and the risk of thrombosis","volume":"21","author":"Kamphuisen","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0685","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/MBC.0000000000000009","article-title":"Changes in the levels of endothelium-derived coagulation parameters in nonalcoholic fatty liver disease","volume":"25","author":"Bilgir","year":"2014","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2020.12.002_bb0690","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2014.03.013","article-title":"Procoagulant imbalance in patients with non-alcoholic fatty liver disease","volume":"61","author":"Tripodi","year":"2014","journal-title":"J. Hepatol."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2020.12.002_bb0695","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jth.12225","article-title":"The secretion of von Willebrand factor from endothelial cells; an increasingly complicated story","volume":"11","author":"Nightingale","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.12.002_bb0700","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2018-02-769000","article-title":"Inflammation, von Willebrand factor, and ADAMTS13","volume":"132","author":"Chen","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.12.002_bb0705","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/jhep.2001.29628","article-title":"Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients","volume":"34","author":"Crespo","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0710","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","article-title":"Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2","volume":"44","author":"Haukeland","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0715","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.12.002_bb0720","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1538-7836.2008.02989.x","article-title":"Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells","volume":"6","author":"Cao","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.12.002_bb0725","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-0037-1613999","article-title":"The factor VIII acute phase response requires the participation of NFkappaB and C\/EBP","volume":"84","author":"Begbie","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.12.002_bb0730","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1478-3231.2010.02375.x","article-title":"Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease","volume":"31","author":"Kotronen","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.thromres.2020.12.002_bb0735","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000446566","article-title":"Serum pentraxin 3 fragment as a noninvasive marker of nonalcoholic fatty liver disease in obese children and adolescents","volume":"86","author":"Hamza","year":"2016","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.thromres.2020.12.002_bb0740","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/liv.14384","article-title":"The endothelial function biomarker soluble E-selectin is associated with nonalcoholic fatty liver disease","volume":"40","author":"Simons","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.thromres.2020.12.002_bb0745","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1160\/TH07-03-0207","article-title":"PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets","volume":"98","author":"Dole","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2020.12.002_bb0750","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1538-7836.2007.02517.x","article-title":"Platelets, inflammation and atherosclerosis","volume":"5","author":"Lindemann","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.12.002_bb0755","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1586\/erc.10.92","article-title":"Activated platelets and atherosclerosis","volume":"8","author":"Aukrust","year":"2010","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.thromres.2020.12.002_bb0760","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/CIRCULATIONAHA.107.706986","article-title":"CC chemokine ligand-5 (CCL5\/RANTES) and CC chemokine ligand-18 (CCL18\/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms","volume":"116","author":"Kraaijeveld","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2020.12.002_bb0765","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1471-4906(00)01812-3","article-title":"RANTES: a versatile and controversial chemokine","volume":"22","author":"Appay","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0770","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1038\/s41598-018-25699-9","article-title":"Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2020.12.002_bb0775","first-page":"675","article-title":"Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation","volume":"3","author":"Kirovski","year":"2010","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0780","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.trsl.2016.08.006","article-title":"Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress","volume":"180","author":"Li","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.thromres.2020.12.002_bb0785","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fimmu.2016.00236","article-title":"The emerging role of NETs in venous thrombosis and Immunothrombosis","volume":"7","author":"Kimball","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0790","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/hep.29914","article-title":"Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis","volume":"68","author":"van der Windt","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0795","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0800","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jhep.2010.08.018","article-title":"Platelet production and destruction in liver cirrhosis","volume":"54","author":"Pradella","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0805","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/jhep.2003.50209","article-title":"A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis","volume":"37","author":"Kajihara","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0810","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jhep.2011.06.008","article-title":"Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?","volume":"55","author":"Violi","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0815","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1155\/2012\/175849","article-title":"Venous thromboembolism in cirrhosis: a review of the literature","volume":"26","author":"Buresi","year":"2012","journal-title":"Can. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0820","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.3748\/wjg.v12.i48.7725","article-title":"New insights into the coagulopathy of liver disease and liver transplantation","volume":"12","author":"Senzolo","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0825","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0830","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V98.9.2730","article-title":"Changes in health and disease of the metalloprotease that cleaves von Willebrand factor","volume":"98","author":"Mannucci","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.12.002_bb0835","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/gut.2010.235689","article-title":"Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension","volume":"60","author":"La Mura","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2020.12.002_bb0840","first-page":"818","article-title":"Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4","volume":"48","author":"Panasiuk","year":"2001","journal-title":"Hepato-Gastroenterol"},{"key":"10.1016\/j.thromres.2020.12.002_bb0845","first-page":"41","article-title":"Platelet activation in patients with alcoholic liver disease","volume":"30","author":"Ogasawara","year":"2005","journal-title":"Tokai J. Exp. Clin. Med."},{"key":"10.1016\/j.thromres.2020.12.002_bb0850","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1016\/j.thromres.2009.12.002","article-title":"Monocyte-platelet aggregates and platelet micro-particles in patients with post-hepatitic liver cirrhosis","volume":"125","author":"Sayed","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.12.002_bb0855","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.28853","article-title":"Low-grade endotoxemia and platelet activation in cirrhosis","volume":"65","author":"Raparelli","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0860","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.21266","article-title":"Thrombin generation in patients with cirrhosis: the role of platelets","volume":"44","author":"Tripodi","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0865","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hep.21303","article-title":"Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management","volume":"44","author":"Caldwell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0870","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/j.1538-7836.2011.04429.x","article-title":"Hypercoagulability in cirrhosis: causes and consequences","volume":"9","author":"Tripodi","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.12.002_bb0880","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/AIA.0000000000000139","article-title":"The rebalanced hemostasis system in end-stage liver disease and its impact on liver transplantation","volume":"55","author":"Henry","year":"2017","journal-title":"Int. Anesthesiol. Clin."},{"key":"10.1016\/j.thromres.2020.12.002_bb0890","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1007\/s10620-008-0265-3","article-title":"Deep vein thrombosis and pulmonary embolism in cirrhosis patients","volume":"53","author":"Gulley","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.thromres.2020.12.002_bb0895","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/hep4.1317","article-title":"Serum albumin is inversely associated with portal vein thrombosis in cirrhosis","volume":"3","author":"Basili","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.thromres.2020.12.002_bb0900","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gut.46.4.534","article-title":"Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?","volume":"46","author":"Fisher","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2020.12.002_bb0905","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","article-title":"Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development","volume":"51","author":"Zocco","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0910","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0168-8278(92)90153-G","article-title":"Protein-C in patients with alcoholic cirrhosis and other liver-diseases","volume":"14","author":"Bell","year":"1992","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0915","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/jcp.37.5.523","article-title":"Antithrombin III metabolism in patients with liver disease","volume":"37","author":"Knot","year":"1984","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0925","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis","volume":"137","author":"Tripodi","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0930","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0935","doi-asserted-by":"crossref","first-page":"856754","DOI":"10.1155\/2013\/856754","article-title":"Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay","volume":"2013","author":"Youngwon","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.thromres.2020.12.002_bb0940","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2019.03.070","article-title":"AGA clinical practice update: coagulation in cirrhosis","volume":"157","author":"O\u2019Leary","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0945","first-page":"131","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: epidemiology, pathogenesis, and prevention","volume":"1","author":"Baffy","year":"2013","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb0950","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.thromres.2007.10.009","article-title":"Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma","volume":"122","author":"Connolly","year":"2008","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.12.002_bb0955","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12876-017-0668-8","article-title":"Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome","volume":"17","author":"Fujiyama","year":"2017","journal-title":"BMC Gastroenterol."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2020.12.002_bb0960","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0049-3848(15)50432-5","article-title":"The mechanisms of cancer-associated thrombosis","volume":"135","author":"Falanga","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.12.002_bb0965","series-title":"Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis, Gastroenterology","first-page":"1582","volume":"156","author":"Intagliata","year":"2019"},{"key":"10.1016\/j.thromres.2020.12.002_bb0970","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/liv.13500","article-title":"Decreased portal vein velocity is predictive of the development of portal vein thrombosis: a matched case-control study","volume":"38","author":"Stine","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.thromres.2020.12.002_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.cld.2013.12.001","article-title":"Pathophysiology of portal hypertension","volume":"18","author":"Iwakiri","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.thromres.2020.12.002_bb0980","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14366\/usg.15020","article-title":"Altered Doppler flow patterns in cirrhosis patients: an overview","volume":"35","author":"Iranpour","year":"2016","journal-title":"Ultrasonography"},{"key":"10.1016\/j.thromres.2020.12.002_bb0985","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1148\/radiol.14132952","article-title":"Nonalcoholic fatty liver disease: portal hypertension due to outflow block in patients without cirrhosis","volume":"274","author":"Hirooka","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.thromres.2020.12.002_bb0990","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10620-017-4903-5","article-title":"Origins of portal hypertension in nonalcoholic fatty liver disease","volume":"63","author":"Baffy","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.thromres.2020.12.002_bb0995","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0026-2862(03)00021-9","article-title":"Increased NAD(P)H fluorescence with decreased blood flow in the steatotic liver of the obese Zucker rat","volume":"66","author":"Sun","year":"2003","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.thromres.2020.12.002_bb1000","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00007890-199909270-00009","article-title":"The effect of graded steatosis on flow in the hepatic parenchymal microcirculation","volume":"68","author":"Seifalian","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.thromres.2020.12.002_bb1005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jcu.20440","article-title":"Effects of diffuse fatty infiltration of the liver on portal vein flow hemodynamics","volume":"36","author":"Balci","year":"2008","journal-title":"J. Clin. Ultrasound"},{"key":"10.1016\/j.thromres.2020.12.002_bb1010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.mn.7800206","article-title":"Impairment of hepatic microcirculation in fatty liver","volume":"10","author":"Ijaz","year":"2003","journal-title":"Microcirculation"},{"key":"10.1016\/j.thromres.2020.12.002_bb1015","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2008.01.016","article-title":"Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease","volume":"48","author":"Chalasani","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb1020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5604\/16652681.1231562","article-title":"Perspectives on NASH histology: cellular ballooning","volume":"16","author":"Caldwell","year":"2017","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb1025","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","article-title":"Liver sinusoidal endothelial cells: physiology and role in liver diseases","volume":"66","author":"Poisson","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb1030","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1172\/JCI119842","article-title":"Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids","volume":"100","author":"Shah","year":"1997","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.thromres.2020.12.002_bb1035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1034\/j.1600-0676.2000.020001003.x","article-title":"Morphological mechanisms for regulating blood flow through hepatic sinusoids","volume":"20","author":"McCuskey","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.thromres.2020.12.002_bb1040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/01.RES.0000255691.76142.4a","article-title":"Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms","volume":"100","author":"Aird","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.thromres.2020.12.002_bb1045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.thromres.2020.12.002_bb1050","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2016.04.018","article-title":"Sinusoidal communication in liver fibrosis and regeneration","volume":"65","author":"Marrone","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb1055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-8278(85)80770-4","article-title":"Reduction of the increased portal vascular-resistance of the isolated perfused cirrhotic rat-liver by vasodilators","volume":"1","author":"Bhathal","year":"1985","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb1060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2009.03.008","article-title":"Kupffer cells in non-alcoholic fatty liver disease: the emerging view","volume":"51","author":"Baffy","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2020.12.002_bb1065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jth.13906","article-title":"Fibrin fuels fatty liver disease","volume":"16","author":"Lisman","year":"2018","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820306496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820306496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:25:33Z","timestamp":1777472733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820306496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":210,"alternative-id":["S0049384820306496"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.12.002","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}